US CELLULAR CORP (USM) Fundamental Analysis & Valuation

NYSE:USM • US9116841084

Current stock price

77.01 USD
+2.76 (+3.72%)
At close:
77.9 USD
+0.89 (+1.16%)
After Hours:

This USM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. USM Profitability Analysis

1.1 Basic Checks

  • In the past year USM was profitable.
  • In the past year USM had a positive cash flow from operations.
  • Of the past 5 years USM 4 years were profitable.
  • USM had a positive operating cash flow in each of the past 5 years.
USM Yearly Net Income VS EBIT VS OCF VS FCFUSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

  • USM has a worse Return On Assets (-0.38%) than 72.73% of its industry peers.
  • USM's Return On Equity of -0.85% is on the low side compared to the rest of the industry. USM is outperformed by 72.73% of its industry peers.
  • With a Return On Invested Capital value of 1.10%, USM perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for USM is significantly below the industry average of 7.50%.
  • The 3 year average ROIC (1.05%) for USM is below the current ROIC(1.10%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.38%
ROE -0.85%
ROIC 1.1%
ROA(3y)0.13%
ROA(5y)0.85%
ROE(3y)0.32%
ROE(5y)1.91%
ROIC(3y)1.05%
ROIC(5y)1.3%
USM Yearly ROA, ROE, ROICUSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

  • USM has a Operating Margin (3.58%) which is comparable to the rest of the industry.
  • USM's Operating Margin has improved in the last couple of years.
  • USM's Gross Margin of 57.26% is fine compared to the rest of the industry. USM outperforms 68.18% of its industry peers.
  • USM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.58%
PM (TTM) N/A
GM 57.26%
OM growth 3Y-6.02%
OM growth 5Y3.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y0.4%
USM Yearly Profit, Operating, Gross MarginsUSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. USM Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so USM is destroying value.
  • USM has about the same amout of shares outstanding than it did 1 year ago.
  • USM has less shares outstanding than it did 5 years ago.
  • USM has a better debt/assets ratio than last year.
USM Yearly Shares OutstandingUSM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
USM Yearly Total Debt VS Total AssetsUSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • USM has an Altman-Z score of 1.53. This is a bad value and indicates that USM is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.53, USM is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • USM has a debt to FCF ratio of 8.09. This is a slightly negative value and a sign of low solvency as USM would need 8.09 years to pay back of all of its debts.
  • USM has a Debt to FCF ratio (8.09) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.62 indicates that USM is somewhat dependend on debt financing.
  • USM has a Debt to Equity ratio of 0.62. This is comparable to the rest of the industry: USM outperforms 59.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.09
Altman-Z 1.53
ROIC/WACC0.14
WACC7.62%
USM Yearly LT Debt VS Equity VS FCFUSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B

2.3 Liquidity

  • USM has a Current Ratio of 1.70. This is a normal value and indicates that USM is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.70, USM is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • USM has a Quick Ratio of 1.48. This is a normal value and indicates that USM is financially healthy and should not expect problems in meeting its short term obligations.
  • USM has a better Quick ratio (1.48) than 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.48
USM Yearly Current Assets VS Current LiabilitesUSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. USM Growth Analysis

3.1 Past

  • USM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.32%.
  • Measured over the past years, USM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.19% on average per year.
  • The Revenue has decreased by -3.48% in the past year.
  • Measured over the past years, USM shows a decrease in Revenue. The Revenue has been decreasing by -1.29% on average per year.
EPS 1Y (TTM)7.32%
EPS 3Y-26.25%
EPS 5Y-13.19%
EPS Q2Q%80%
Revenue 1Y (TTM)-3.48%
Revenue growth 3Y-2.93%
Revenue growth 5Y-1.29%
Sales Q2Q%-1.19%

3.2 Future

  • The Earnings Per Share is expected to grow by 0.20% on average over the next years.
  • USM is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -42.63% yearly.
EPS Next Y15.94%
EPS Next 2Y25.09%
EPS Next 3Y21.15%
EPS Next 5Y0.2%
Revenue Next Year-2.84%
Revenue Next 2Y-1.42%
Revenue Next 3Y-1.07%
Revenue Next 5Y-42.63%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
USM Yearly Revenue VS EstimatesUSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
USM Yearly EPS VS EstimatesUSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. USM Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 87.51 indicates a quite expensive valuation of USM.
  • 72.73% of the companies in the same industry are cheaper than USM, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.87, USM is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 69.32, the valuation of USM can be described as expensive.
  • 72.73% of the companies in the same industry are cheaper than USM, based on the Price/Forward Earnings ratio.
  • USM's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 38.51.
Industry RankSector Rank
PE 87.51
Fwd PE 69.32
USM Price Earnings VS Forward Price EarningsUSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 63.64% of the companies in the same industry are cheaper than USM, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, USM is valued a bit more expensive than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.54
EV/EBITDA 11.58
USM Per share dataUSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • USM's earnings are expected to grow with 21.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.49
PEG (5Y)N/A
EPS Next 2Y25.09%
EPS Next 3Y21.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. USM Dividend Analysis

5.1 Amount

  • USM has a Yearly Dividend Yield of 7.49%, which is a nice return.
  • USM's Dividend Yield is rather good when compared to the industry average which is at 6.14. USM pays more dividend than 81.82% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, USM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.49%

5.2 History

  • USM does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
USM Yearly Dividends per shareUSM Yearly Dividends per shareYearly Dividends per share 2025 5 10 15 20

5.3 Sustainability

DP0%
EPS Next 2Y25.09%
EPS Next 3Y21.15%
USM Yearly Income VS Free CF VS DividendUSM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

USM Fundamentals: All Metrics, Ratios and Statistics

US CELLULAR CORP

NYSE:USM (8/11/2025, 8:07:46 PM)

After market: 77.9 +0.89 (+1.16%)

77.01

+2.76 (+3.72%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)08-11
Earnings (Next)10-30
Inst OwnersN/A
Inst Owner Change2.88%
Ins OwnersN/A
Ins Owner Change0%
Market Cap6.55B
Revenue(TTM)3.77B
Net Income(TTM)-39.00M
Analysts75.56
Price Target76.61 (-0.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.49%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)76.69%
Min EPS beat(2)-39.44%
Max EPS beat(2)192.83%
EPS beat(4)3
Avg EPS beat(4)73.51%
Min EPS beat(4)-39.44%
Max EPS beat(4)192.83%
EPS beat(8)5
Avg EPS beat(8)113.75%
EPS beat(12)6
Avg EPS beat(12)56.53%
EPS beat(16)8
Avg EPS beat(16)47.35%
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-5.4%
Max Revenue beat(2)-0.57%
Revenue beat(4)0
Avg Revenue beat(4)-2.4%
Min Revenue beat(4)-5.4%
Max Revenue beat(4)-0.57%
Revenue beat(8)1
Avg Revenue beat(8)-2.52%
Revenue beat(12)3
Avg Revenue beat(12)-2.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.08%
PT rev (1m)2.74%
PT rev (3m)1.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 87.51
Fwd PE 69.32
P/S 1.76
P/FCF 18.54
P/OCF 7.79
P/B 1.43
P/tB 1636.46
EV/EBITDA 11.58
EPS(TTM)0.88
EY1.14%
EPS(NY)1.11
Fwd EY1.44%
FCF(TTM)4.15
FCFY5.39%
OCF(TTM)9.88
OCFY12.83%
SpS43.66
BVpS53.94
TBVpS0.05
PEG (NY)5.49
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.85%
ROCE 1.39%
ROIC 1.1%
ROICexc 1.12%
ROICexgc 2.19%
OM 3.58%
PM (TTM) N/A
GM 57.26%
FCFM 9.51%
ROA(3y)0.13%
ROA(5y)0.85%
ROE(3y)0.32%
ROE(5y)1.91%
ROIC(3y)1.05%
ROIC(5y)1.3%
ROICexc(3y)1.07%
ROICexc(5y)1.37%
ROICexgc(3y)2.08%
ROICexgc(5y)2.45%
ROCE(3y)1.33%
ROCE(5y)1.64%
ROICexgc growth 3Y-6.62%
ROICexgc growth 5Y1.42%
ROICexc growth 3Y-9.23%
ROICexc growth 5Y-3.33%
OM growth 3Y-6.02%
OM growth 5Y3.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y0.4%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.09
Debt/EBITDA 3.55
Cap/Depr 73.45%
Cap/Sales 13.12%
Interest Coverage 250
Cash Conversion 105.53%
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.48
Altman-Z 1.53
F-Score5
WACC7.62%
ROIC/WACC0.14
Cap/Depr(3y)121.94%
Cap/Depr(5y)166.9%
Cap/Sales(3y)20.71%
Cap/Sales(5y)28.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.32%
EPS 3Y-26.25%
EPS 5Y-13.19%
EPS Q2Q%80%
EPS Next Y15.94%
EPS Next 2Y25.09%
EPS Next 3Y21.15%
EPS Next 5Y0.2%
Revenue 1Y (TTM)-3.48%
Revenue growth 3Y-2.93%
Revenue growth 5Y-1.29%
Sales Q2Q%-1.19%
Revenue Next Year-2.84%
Revenue Next 2Y-1.42%
Revenue Next 3Y-1.07%
Revenue Next 5Y-42.63%
EBIT growth 1Y-23.56%
EBIT growth 3Y-8.78%
EBIT growth 5Y2.21%
EBIT Next Year20168.2%
EBIT Next 3Y476.6%
EBIT Next 5Y95.74%
FCF growth 1Y406.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.47%
OCF growth 3Y3.26%
OCF growth 5Y4.05%

US CELLULAR CORP / USM Fundamental Analysis FAQ

What is the fundamental rating for USM stock?

ChartMill assigns a fundamental rating of 3 / 10 to USM.


What is the valuation status for USM stock?

ChartMill assigns a valuation rating of 1 / 10 to US CELLULAR CORP (USM). This can be considered as Overvalued.


Can you provide the profitability details for US CELLULAR CORP?

US CELLULAR CORP (USM) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for USM stock?

The Price/Earnings (PE) ratio for US CELLULAR CORP (USM) is 87.51 and the Price/Book (PB) ratio is 1.43.


What is the earnings growth outlook for US CELLULAR CORP?

The Earnings per Share (EPS) of US CELLULAR CORP (USM) is expected to grow by 15.94% in the next year.